Accession Number: | 0000874015-19-000087 |
Date: | 2019-07-01 |
Issuer: | IONIS PHARMACEUTICALS INC (IONS) |
Original Submission Date: |
HOUGEN ELIZABETH L
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD, CA 92010
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-07-01 | J | 105 | a | $45.70 | 20,055 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | reporting 105 shares acquired under the ionis pharmaceuticals, inc. amended and restated 2000 employee stock purchase plan on july 1, 2019. these 105 shares may not be sold until january 2, 2020. |